Generic Name ROZANOLIXIZUMAB-NOLI Review Date Began Wed, 07/05/2023 - 12:00 Review Date Completed Tue, 08/15/2023 - 12:00 Conclusion Clinical Edit Committee Month Sun, 10/01/2023 - 12:00